High-Level Commercial Due Diligence in Digital Pathology
Investors
13
4
Due Diligence
Objective
An early-stage venture firm requested a high-level commercial due diligence of a potential investment
Our Approach
Secondary Research
- Assessed the competitive landscape and clinical workflows in specific indications to understand how the company fits in
Primary Research
- Conducted 13 interviews with experts from biopharma, clinical settings, and industry to assess the company's value proposition
Outcome
DeciBio presented a deliverable detailing the digital pathology landscape, the company's niche in the space, and potential go-to-market plans and considerations.
Quantitative Analysis
- Company revenue estimation using comparable competitors as benchmarks
Qualitative Analysis
- Potential clinical pricing / commercialization models
- Timeline to clinic
- Clinical go-to-market considerations by geography and stakeholder type
Related Client Results
MRD Monitoring Market Assessment and Strategy
Biomarker and Diagnostics Strategy
Go-to-Market Strategy
Market Landscaping and Sizing
Cell Therapy Market Trends and Revenue Forecast
Revenue Projection
RWD Biobank Offering Go-to-Market Strategy
Voice-of-Customer Research
Go-to-Market Strategy
Pricing Strategy
Competitive Analysis
